The NHLBI Update | June 2024
National Heart, Lung, and Blood Institute
Advancing science. Improving health.
Intravenous Acetaminophen Shields Sepsis Patients from Organ Damage?
An NIH-funded clinical trial, published in JAMA, found that treating sepsis patients with intravenous acetaminophen may reduce the risk of organ injury and respiratory distress syndrome.
Track Your Steps for a Healthier Heart
Women who get around 7,000 steps each day have a lower risk of developing heart disease or dying prematurely, according to a recent study from the Women’s Health Initiative.
Finalists Announced in NIH Build UP Trust Challenge
The NIH launched the Build UP Trust Challenge to identify creative ways to increase research participation and the adoption of medical care by building trust and improving engagement with historically underserved communities.
NHLBI-funded Engineer Designs Heart-monitoring Smart Bra
NHLBI grantees designed a smart bra that collects data on heart, lung, hormone, and metabolism function. The technology uses patented, textile-based sensors, built into the band of the bra.
领英推荐
New Lung Function Scoring System May Change Disease Status for Millions
Scientists have revised the scoring system for lung function tests. The updated criteria may create new treatment opportunities for patients previously ineligible for advanced medical treatment.
Living Well With Sickle Cell
Sickle cell disease affects approximately 100,000 people in the U.S. Read and share resources to help people with sickle cell understand their condition, manage their pain, and live well.
What Are Sleep Deprivation and Deficiency?
Sleeping is a basic human need, like eating, drinking, and breathing, and is vital for good health. Despite this, 1 in 3 adults in the U.S. report not getting enough rest or sleep every day.
Calling All Lymphatic Disease Experts and Patients!
The National Commission on Lymphatic Diseases?aims to better understand the burden of lymphatic diseases. They are collecting input from scientists, clinicians, caregivers, and patients.
The NHLBI's Annual Sickle Cell Disease Research Meeting
From August 12–14, the NHLBI is hosting a 3-day hybrid meeting for sickle cell disease researchers, healthcare providers, and other stakeholders to discuss the latest innovations in the field.